Reuters logo
4 months ago
BRIEF-Cytokinetics announces start of second cohort in Phase 2 clinical trial of CK-2127107
March 29, 2017 / 12:10 PM / 4 months ago

BRIEF-Cytokinetics announces start of second cohort in Phase 2 clinical trial of CK-2127107

1 Min Read

March 29 (Reuters) - Cytokinetics Inc

* Cytokinetics announces start of second cohort in phase 2 clinical trial of CK-2127107 in patients with spinal muscular atrophy Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below